FDG-PET is not useful in early pancreatic cancer diagnosis

Better tools for early detection and accurate staging of pancreatic cancer are needed. The role of 18F-fluorodeoxyglucose (FDG)-PET in this setting is controversial. The results of a large retrospective study analyzing the value of FDG-PET in the diagnosis of pancreatic ductal adenocarcinoma are dis...

Full description

Saved in:
Bibliographic Details
Main Authors: Strobel, Oliver (Author) , Büchler, Markus W. (Author)
Format: Article (Journal)
Language:English
Published: 2013
In: Nature reviews. Gastroenterology & hepatology
Year: 2013, Volume: 10, Issue: 4, Pages: 203-205
ISSN:1759-5053
DOI:10.1038/nrgastro.2013.42
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/nrgastro.2013.42
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/nrgastro.2013.42
Get full text
Author Notes:Oliver Strobel & Markus W. Büchler
Description
Summary:Better tools for early detection and accurate staging of pancreatic cancer are needed. The role of 18F-fluorodeoxyglucose (FDG)-PET in this setting is controversial. The results of a large retrospective study analyzing the value of FDG-PET in the diagnosis of pancreatic ductal adenocarcinoma are discussed here.
Item Description:Gesehen am 16.03.2022
Physical Description:Online Resource
ISSN:1759-5053
DOI:10.1038/nrgastro.2013.42